HGUG Marañón

Madrid 28007

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Renal Cell, Gastric Cancer, Gastroesophageal Junction Cancer, Metastatic Breast Cancer, Pancreatic Ductal Carcinoma

Studies at this site

• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early
• Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer — Completed